Australia's most trusted
source of pharma news
Thursday, 18 September 2025
Posted 16 September 2025 PM
Another long-standing member of the global Novo Nordisk team is departing after he took his own advice to embrace change - and tendered his resignation.
Lars Fogh Iversen left his role as Senior Vice President, External & Exploratory Innovation this month, after 28 years and nine months with the company. And perhaps his timing couldn't have been better, coming just days before an announcement the company would shed 9000 jobs, starting immediately.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.